The World Health Organisation (WHO), has felt the need to conduct this training to build local capacities in poor countries to bridge the gap and enhance local production
The company has already embarked upon significant expansion in Turkey
The company has now received the renewed GMP (Good Manufacturing Practices) certificate thereby confirming the successful closure of the inspection
The GMP certificate is valid for three years until April 2024.
The company has received a certificate of Good Manufacturing Practice compliance from the Medicines & Healthcare products Regulatory Agency (MHRA) UK
New digital platform provides global sponsors with live visibility into R&D, process development and GMP manufacturing operations, enhancing collaboration and decision-making
Clearing 19 biologics for Europe market
The sale is part of a broader strategy to streamline its asset footprint and concentrate investment on core growth areas
New Tracxn report highlights growing investor confidence in automated cell therapy production, with Cellares and Ori Biotech dominating funding and regulatory milestones
New facility will open by October 2026 and house 500 process development specialists
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
